Headline News

 

In Order to Simplify Manufacturing Supply Chain for Advanced Therapies, Vineti and WuXi AppTec Collaborate

Posted on November 12, 2019

U.S. FDA Complete Response Letter Received for Lipocine’s TLANDO™

Posted on November 12, 2019

17 Abstracts to be Presented by ViiV Healthcare from its Portfolio Addressing the Diverse Needs of People Living with HIV

Posted on November 12, 2019

US FDA Approval Received by Lupin for Zileuton Extended-Release Tablets

Posted on November 12, 2019

Lupin Annonuces Agreement to Divest its Stake in Kyowa to Unison

Posted on November 12, 2019

Chlorantraniliprole Announced as NATCO’s 1st Key Product in Crop Health Sciences for India

Posted on November 12, 2019

$24 Million to be Invested by Thermo Fisher Scientific to Increase Global Bioproduction Capabilities

Posted on November 05, 2019

Depth of Immunology Portfolio and Pipeline to be Showcased by AbbVie at the 2019 ACR/ARP Annual Meeting

Posted on November 05, 2019

Sanofi Announces FDA Approval for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

Posted on November 05, 2019

Novartis Announces Sandoz Receives US FDA Approval for Long-Acting Oncology Supportive Care Biosimilar Ziextenzo™ (pegfilgrastim-bmez)

Posted on November 05, 2019

Final USFDA Approval Received by Zydus for Cisatracurium Besylate Injection USP

Posted on November 05, 2019

EIR from U.S. FDA Received by Biocon for their Biologics Drug Products Facility in Bengaluru

Posted on November 05, 2019

Novartis Shows Rresults of Cosentyx® Versus Humira®* From First-of-its-kind Head-to-head Trial in Psoriatic Arthritis

Posted on November 05, 2019

GSK Reports on their M72/AS01E Candidate Vaccine

Posted on October 29, 2019

AstraZeneca Announce Results from Phase III POSEIDON trial for 1st-line treatment of Stage IV non-small cell lung cancer

Posted on October 29, 2019